These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 31173265

  • 1. Ethyl pyruvate suppresses the growth, invasion and migration and induces the apoptosis of non‑small cell lung cancer cells via the HMGB1/RAGE axis and the NF‑κB/STAT3 pathway.
    Liu Q, Huo Y, Zheng H, Zhao J, Jia L, Wang P.
    Oncol Rep; 2019 Aug; 42(2):817-825. PubMed ID: 31173265
    [Abstract] [Full Text] [Related]

  • 2. Ethyl pyruvate administration suppresses growth and invasion of gallbladder cancer cells via downregulation of HMGB1-RAGE axis.
    Li ML, Wang XF, Tan ZJ, Dong P, Gu J, Lu JH, Wu XS, Zhang L, Ding QC, Wu WG, Rao LH, Mu JS, Yang JH, Weng H, Ding Q, Zhang WJ, Chen L, Liu YB.
    Int J Immunopathol Pharmacol; 2012 Aug; 25(4):955-65. PubMed ID: 23298486
    [Abstract] [Full Text] [Related]

  • 3. Inhibitory effects of ethyl pyruvate administration on human gastric cancer growth via regulation of the HMGB1-RAGE and Akt pathways in vitro and in vivo.
    Zhang J, Zhu JS, Zhou Z, Chen WX, Chen NW.
    Oncol Rep; 2012 May; 27(5):1511-9. PubMed ID: 22246223
    [Abstract] [Full Text] [Related]

  • 4. Ethyl pyruvate inhibits proliferation and induces apoptosis of hepatocellular carcinoma via regulation of the HMGB1-RAGE and AKT pathways.
    Cheng P, Dai W, Wang F, Lu J, Shen M, Chen K, Li J, Zhang Y, Wang C, Yang J, Zhu R, Zhang H, Zheng Y, Guo CY, Xu L.
    Biochem Biophys Res Commun; 2014 Jan 24; 443(4):1162-8. PubMed ID: 24361892
    [Abstract] [Full Text] [Related]

  • 5. HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma.
    Pellegrini L, Xue J, Larson D, Pastorino S, Jube S, Forest KH, Saad-Jube ZS, Napolitano A, Pagano I, Negi VS, Bianchi ME, Morris P, Pass HI, Gaudino G, Carbone M, Yang H.
    Oncotarget; 2017 Apr 04; 8(14):22649-22661. PubMed ID: 28186988
    [Abstract] [Full Text] [Related]

  • 6. RIP1 Is a Novel Component of γ-ionizing Radiation-Induced Invasion of Non-Small Cell Lung Cancer Cells.
    Kang AR, Cho JH, Lee NG, Song JY, Hwang SG, Lee DH, Um HD, Park JK.
    Int J Mol Sci; 2020 Jun 28; 21(13):. PubMed ID: 32605153
    [Abstract] [Full Text] [Related]

  • 7. Autophagic secretion of HMGB1 from cancer-associated fibroblasts promotes metastatic potential of non-small cell lung cancer cells via NFκB signaling.
    Ren Y, Cao L, Wang L, Zheng S, Zhang Q, Guo X, Li X, Chen M, Wu X, Furlong F, Meng Z, Xu K.
    Cell Death Dis; 2021 Sep 22; 12(10):858. PubMed ID: 34552063
    [Abstract] [Full Text] [Related]

  • 8. SNHG14 silencing suppresses the progression and promotes cisplatin sensitivity in non-small cell lung cancer.
    Jiao P, Hou J, Yao M, Wu J, Ren G.
    Biomed Pharmacother; 2019 Sep 22; 117():109164. PubMed ID: 31252267
    [Abstract] [Full Text] [Related]

  • 9. HMGB1 knock-down promoting tumor cells viability and arrest pro-apoptotic proteins via Stat3/NFκB in HepG2 cells.
    Alduais S, Alduais Y, Wu X, Li H, Mao J.
    Biofactors; 2018 Nov 22; 44(6):570-576. PubMed ID: 30375073
    [Abstract] [Full Text] [Related]

  • 10. High mobility group box 1 promotes the epithelial-to-mesenchymal transition in prostate cancer PC3 cells via the RAGE/NF-κB signaling pathway.
    Zhang J, Shao S, Han D, Xu Y, Jiao D, Wu J, Yang F, Ge Y, Shi S, Li Y, Wen W, Qin W.
    Int J Oncol; 2018 Aug 22; 53(2):659-671. PubMed ID: 29845254
    [Abstract] [Full Text] [Related]

  • 11. Downregulation of miR-205 contributes to epithelial-mesenchymal transition and invasion in triple-negative breast cancer by targeting HMGB1-RAGE signaling pathway.
    Wang L, Kang FB, Wang J, Yang C, He DW.
    Anticancer Drugs; 2019 Mar 22; 30(3):225-232. PubMed ID: 30334817
    [Abstract] [Full Text] [Related]

  • 12. Over-regulation of microRNA-133b inhibits cell proliferation of cisplatin-induced non-small cell lung cancer cells through PI3K/Akt and JAK2/STAT3 signaling pathway by targeting EGFR.
    Li B, Ding CM, Li YX, Peng JC, Geng N, Qin WW.
    Oncol Rep; 2018 Mar 22; 39(3):1227-1234. PubMed ID: 29344640
    [Abstract] [Full Text] [Related]

  • 13. Downregulation of Rab17 promotes cell proliferation and invasion in non-small cell lung cancer through STAT3/HIF-1α/VEGF signaling.
    Wang M, Wang W, Ding J, Wang J, Zhang J.
    Thorac Cancer; 2020 Feb 22; 11(2):379-388. PubMed ID: 31841274
    [Abstract] [Full Text] [Related]

  • 14. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
    Pang L, Han S, Jiao Y, Jiang S, He X, Li P.
    Int J Oncol; 2017 Jul 22; 51(1):25-38. PubMed ID: 28534943
    [Abstract] [Full Text] [Related]

  • 15. Glutathione S‑transferase ω 1 promotes the proliferation, migration and invasion, and inhibits the apoptosis of non‑small cell lung cancer cells, via the JAK/STAT3 signaling pathway.
    Wang K, Zhang FL, Jia W.
    Mol Med Rep; 2021 Jan 22; 23(1):. PubMed ID: 33236161
    [Abstract] [Full Text] [Related]

  • 16. High-Mobility Group Box 1 Mediates Fibroblast Activity via RAGE-MAPK and NF-κB Signaling in Keloid Scar Formation.
    Kim J, Park JC, Lee MH, Yang CE, Lee JH, Lee WJ.
    Int J Mol Sci; 2017 Dec 28; 19(1):. PubMed ID: 29283384
    [Abstract] [Full Text] [Related]

  • 17. Anti-proliferation and anti-metastasis effect of barbaloin in non-small cell lung cancer via inactivating p38MAPK/Cdc25B/Hsp27 pathway.
    Zhang Z, Rui W, Wang ZC, Liu DX, Du L.
    Oncol Rep; 2017 Aug 28; 38(2):1172-1180. PubMed ID: 28656293
    [Abstract] [Full Text] [Related]

  • 18. HMGB1-RAGE signaling facilitates Ras-dependent Yap1 expression to drive colorectal cancer stemness and development.
    Qian F, Xiao J, Gai L, Zhu J.
    Mol Carcinog; 2019 Apr 28; 58(4):500-510. PubMed ID: 30456802
    [Abstract] [Full Text] [Related]

  • 19. Up-regulated HMGB1 in the pleural effusion of non-small cell lung cancer (NSCLC) patients reduces the chemosensitivity of NSCLC cells.
    Ma Y, Kang S, Wu X, Han B, Jin Z, Guo Z.
    Tumori; 2018 Oct 28; 104(5):338-343. PubMed ID: 28885675
    [Abstract] [Full Text] [Related]

  • 20. Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma.
    Zhang T, Guan XW, Gribben JG, Liu FT, Jia L.
    Cell Death Dis; 2019 Apr 15; 10(5):330. PubMed ID: 30988279
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.